RecruitingNot ApplicableNCT06907472

Diabetes Management for Primary Healthcare Centers.

Integrating Diabetes Care Into Primary Healthcare Centers in Abuja, Nigeria: A Pilot Study


Sponsor

University of Abuja

Enrollment

106 participants

Start Date

Sep 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study, "Integrating diabetes care into Primary Healthcare Centers (PHCs) in Abuja, Nigeria: a pilot study," is to screen, diagnose, treat, and educate diabetes patients in two selected PHCs in Abuja. This single-arm pilot trial will test the feasibility of integrated diabetes care, measure the implementation outcomes, and explore the effectiveness of the strategy bundle using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new diabetes care model at primary healthcare centers to see if a structured approach to managing type 2 diabetes in the community improves patient outcomes. **You may be eligible if...** - You are 18 years or older - You have uncomplicated type 2 diabetes **You may NOT be eligible if...** - You are under 18 years old - You have type 1 diabetes - You are currently in prison or detained - You have severe high blood pressure (systolic ≥180 or diastolic ≥110) - You have had a stroke, heart failure, chronic kidney disease, or diabetic foot ulcer - You are pregnant - You are over 60 with poorly controlled blood sugar even on maximum doses of metformin and glibenclamide Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGProtocol-based treatment

PROTOCOL: Step 1: Metformin 500 mg daily Step 2: Metformin 1000 mg daily Step 3: Metformin 1000 mg twice daily Step 4: Metformin 1000 mg twice daily + glibenclamide 5 mg daily Step 5: Metformin 1000 mg twice daily + glibenclamide 5 mg twice daily


Locations(2)

Kagini PHC, Abuja Municipal Area council (AMAC)

Abuja, Federal Capital Territory, Nigeria

Deidei PHC, Bwari Area Council

Abuja, Federal Capital Territory, Nigeria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06907472


Related Trials